APA (7th ed.) Citation

L, D. A., P, G., L, P., G, M., NY, B., MJ, B., & A, D. S. (2025). De-escalation of dupilumab for chronic rhinosinusitis with nasal polyps: Analysis of outcomes after modified dosing regimen. Rhinology, 63(6), 765. https://doi.org/10.4193/Rhin25.151

Chicago Style (17th ed.) Citation

L, Dâ Ascanio, Gradoni P, Pierucci L, Motta G, BuSaba NY, Brenner MJ, and Di Stadio A. "De-escalation of Dupilumab for Chronic Rhinosinusitis with Nasal Polyps: Analysis of Outcomes After Modified Dosing Regimen." Rhinology 63, no. 6 (2025): 765. https://doi.org/10.4193/Rhin25.151.

MLA (9th ed.) Citation

L, Dâ Ascanio, et al. "De-escalation of Dupilumab for Chronic Rhinosinusitis with Nasal Polyps: Analysis of Outcomes After Modified Dosing Regimen." Rhinology, vol. 63, no. 6, 2025, p. 765, https://doi.org/10.4193/Rhin25.151.